Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
Title
Grant Type
Focus Area
Country
Application Due Date
BCMA-Directed Bispecific Antibody Treatment in Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Research on MBL producing Enterobacterales and/or Stenotrophomonas maltophilia
Release Date:
Review Process: Pfizer Internal
Research Hospital Austria, Brazil, China, France, Germany, Greece, India, Italy, Mexico, Saudi Arabia, Spain, Taiwan, Turkey, United Kingdom
Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease All
Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)
Release Date:
Partner: Sumitomo Pharma
Review Process: Pfizer Internal
Education Oncology USA
Title
Grant Type
Focus Area
Country
Application Due Date
Acute Lymphoblastic Leukemia Peer-to-Peer Education & Support
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
PARP-inhibitor Combination Treatments in Prostate Cancer
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Optimizing Patient Access to CDK 4/6 Inhibitors in the Armamentarium Against Metastatic Breast Cancer
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Understanding healthcare disparities in Atopic Dermatitis and Alopecia Areata patients
Release Date:
Review Process: Pfizer Internal
Quality Improvement Inflammation & Immunology All
ADVANCE: Global Awards for Advancing Chronic Pain Research
Release Date:
Review Process: Expert Review Panel
Research Internal Medicine All
Enhancing the Understanding of Health Maintenance in the Management of IBD
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Outpatient Management of COVID-19
Release Date:
Review Process: Pfizer Internal
Education Hospital Albania, Andorra, Armenia, Austria, Azerbaijan, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Luxembourg, Macedonia, The Former Yugoslav, Malta, Moldova, Republic of, Monaco, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slovakia (Slovak Republic), Slovenia, Spain, Sweden, Switzerland, Tajikistan, Turkey, Turkmenistan, Ukraine, United Kingdom, Uzbekistan
Emerging Therapies in Alopecia Areata for Dermatologists - United States
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Virtual Programs for Rheumatology Education
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
2021/2022 Global NASH ASPIRE
Release Date:
Review Process: Expert Review Panel
Research Internal Medicine All
Addressing Knowledge Gaps in Alopecia Areata and Atopic Dermatitis (Global (excluding the US)
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology All
2021/2022 Global Obesity ASPIRE
Release Date:
Review Process: Expert Review Panel
Research Internal Medicine All